Recent Advances in Remote Pulmonary Artery Pressure Monitoring for Patients with Chronic Heart Failure: Current Evidence and Future Perspectives.


Journal

Sensors (Basel, Switzerland)
ISSN: 1424-8220
Titre abrégé: Sensors (Basel)
Pays: Switzerland
ID NLM: 101204366

Informations de publication

Date de publication:
26 Jan 2023
Historique:
received: 28 12 2022
revised: 20 01 2023
accepted: 24 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 15 2 2023
Statut: epublish

Résumé

Chronic heart failure (HF) is associated with high hospital admission rates and has an enormous burden on hospital resources worldwide. Ideally, detection of worsening HF in an early phase would allow physicians to intervene timely and proactively in order to prevent HF-related hospitalizations, a concept better known as remote hemodynamic monitoring. After years of research, remote monitoring of pulmonary artery pressures (PAP) has emerged as the most successful technique for ambulatory hemodynamic monitoring in HF patients to date. Currently, the CardioMEMS and Cordella HF systems have been tested for pulmonary artery pressure monitoring and the body of evidence has been growing rapidly over the past years. However, several ongoing studies are aiming to fill the gap in evidence that is still very clinically relevant, especially for the European setting. In this comprehensive review, we provide an overview of all available evidence for PAP monitoring as well as a detailed discussion of currently ongoing studies and future perspectives for this promising technique that is likely to impact HF care worldwide.

Identifiants

pubmed: 36772403
pii: s23031364
doi: 10.3390/s23031364
pmc: PMC9921931
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

J Am Coll Cardiol. 2014 Apr 1;63(12):1123-1133
pubmed: 24491689
Lancet. 2011 Feb 19;377(9766):616-8
pubmed: 21315440
Am J Cardiol. 2022 Dec 1;184:56-62
pubmed: 36184350
J Am Heart Assoc. 2021 Feb;10(5):e017619
pubmed: 33626889
Lancet. 2016 Jan 30;387(10017):453-61
pubmed: 26560249
Eur J Heart Fail. 2022 Dec;24(12):2320-2330
pubmed: 36054647
Lancet. 2016 Jan 30;387(10017):408-10
pubmed: 26560248
Am Heart J. 2019 Aug;214:18-27
pubmed: 31150790
ESC Heart Fail. 2022 Aug;9(4):2170-2180
pubmed: 35588235
ESC Heart Fail. 2022 Feb;9(1):48-56
pubmed: 34882989
JAMA Cardiol. 2019 Jun 1;4(6):556-563
pubmed: 31090869
Future Cardiol. 2022 Mar;18(3):173-183
pubmed: 34697954
J Card Fail. 2023 Jan;29(1):56-66
pubmed: 36332900
Pharmacoeconomics. 2020 Nov;38(11):1219-1236
pubmed: 32812149
Clin Res Cardiol. 2022 Nov;111(11):1245-1255
pubmed: 35246723
JACC Heart Fail. 2021 Nov;9(11):784-794
pubmed: 34509410
Rev Port Cardiol. 2022 May;41(5):381-390
pubmed: 34840416
Circ Heart Fail. 2014 Nov;7(6):935-44
pubmed: 25286913
J Am Coll Cardiol. 2017 Oct 10;70(15):1875-1886
pubmed: 28982501
ESC Heart Fail. 2020 Oct;7(5):2071-2073
pubmed: 32588973
Lancet. 2021 Sep 11;398(10304):991-1001
pubmed: 34461042
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Circ Heart Fail. 2017 Jan;10(1):
pubmed: 28062538
Eur J Heart Fail. 2020 Oct;22(10):1891-1901
pubmed: 32592227
J Am Coll Cardiol. 2022 May 3;79(17):e263-e421
pubmed: 35379503
Circ Heart Fail. 2020 Aug;13(8):e006863
pubmed: 32757642
Med Clin (Barc). 2021 Jan 8;156(1):26-28
pubmed: 33059937
J Am Coll Cardiol. 2017 Jul 18;70(3):389-398
pubmed: 28705321
ESC Heart Fail. 2021 Jun;8(3):2144-2153
pubmed: 33751806
Lancet. 2021 Sep 11;398(10304):935-936
pubmed: 34461039
Circ Heart Fail. 2021 Jun;14(6):e007892
pubmed: 34129363
ESC Heart Fail. 2022 Aug;9(4):2511-2517
pubmed: 35560987
ESC Heart Fail. 2020 Jun;7(3):865-872
pubmed: 32031758
J Card Fail. 2011 Apr;17(4):282-91
pubmed: 21440865
Circulation. 2008 Sep 30;118(14):1433-41
pubmed: 18794390
J Am Coll Cardiol. 2017 May 16;69(19):2357-2365
pubmed: 28330751
ESC Heart Fail. 2021 Apr;8(2):1706-1710
pubmed: 33522140
Arch Intern Med. 2008 Apr 28;168(8):847-54
pubmed: 18443260
Am Heart J. 2007 Aug;154(2):260-6
pubmed: 17643574
N Engl J Med. 2021 Oct 14;385(16):1451-1461
pubmed: 34449189
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
Eur J Heart Fail. 2021 Sep;23(9):1499-1511
pubmed: 34132001
Eur J Heart Fail. 2019 Nov;21(11):1306-1325
pubmed: 31523902
ESC Heart Fail. 2022 Dec;9(6):3858-3867
pubmed: 35916354
Int J Cardiol. 2018 Nov 15;271:169-173
pubmed: 30093137
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829
Circ Heart Fail. 2010 Sep;3(5):580-7
pubmed: 20562255
Lancet. 2022 Sep 3;400(10354):757-767
pubmed: 36041474
J Am Coll Cardiol. 2007 Dec 18;50(25):2375-82
pubmed: 18154961
Neth Heart J. 2020 Jan;28(1):16-26
pubmed: 31776915
Circulation. 2018 Feb 27;137(9):961-972
pubmed: 29483172
Lancet. 2011 Feb 19;377(9766):658-66
pubmed: 21315441
N Engl J Med. 2022 Sep 22;387(12):1089-1098
pubmed: 36027570
Circ Heart Fail. 2016 Jun;9(6):
pubmed: 27220593
JACC Heart Fail. 2019 Jan;7(1):13-21
pubmed: 30606482
J Am Coll Cardiol. 2018 Jul 24;72(4):351-366
pubmed: 30025570
Sensors (Basel). 2021 Mar 27;21(7):
pubmed: 33801573
Eur J Heart Fail. 2020 Oct;22(10):1912-1919
pubmed: 32476191
Sensors (Basel). 2021 Mar 12;21(6):
pubmed: 33809205
J Card Fail. 2015 Jun;21(6):479-88
pubmed: 25921522
ESC Heart Fail. 2022 Feb;9(1):155-163
pubmed: 34738340
ESC Heart Fail. 2022 Oct;9(5):2862-2872
pubmed: 35686479
Eur J Prev Cardiol. 2021 Aug 9;28(9):957-965
pubmed: 34402878
ASAIO J. 2018 May/Jun;64(3):301-308
pubmed: 28953199
Eur J Heart Fail. 2020 Aug;22(8):1342-1356
pubmed: 32483830
Eur J Heart Fail. 2022 Dec;24(12):2333-2341
pubmed: 36054801

Auteurs

Pascal R D Clephas (PRD)

Department of Cardiology, Thorax Center, Erasmus University Medical Center, 3015GD Rotterdam, The Netherlands.

Dilan Aydin (D)

Department of Cardiology, Thorax Center, Erasmus University Medical Center, 3015GD Rotterdam, The Netherlands.

Sumant P Radhoe (SP)

Department of Cardiology, Thorax Center, Erasmus University Medical Center, 3015GD Rotterdam, The Netherlands.

Jasper J Brugts (JJ)

Department of Cardiology, Thorax Center, Erasmus University Medical Center, 3015GD Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH